These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 5278390

  • 1. [Results of a clinical trial of a newly developped bronchospasmolytic agent (hexoprenalin, Ipradol)].
    Witek F.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):114-7. PubMed ID: 5278390
    [No Abstract] [Full Text] [Related]

  • 2. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
    Racoveanu C, Stanescu DC, Manicatide M, Stroescu V.
    Postgrad Med J; 1971 Mar 19; 47():Suppl:83-6. PubMed ID: 4929399
    [No Abstract] [Full Text] [Related]

  • 3. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study.
    Racoveanu C, Stanescu DC, Manicatide M, Stroescu V.
    Bull Physiopathol Respir (Nancy); 1970 Mar 19; 6(4):809-18. PubMed ID: 4940888
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K.
    Wien Med Wochenschr; 1972 Oct 14; 122(42):606-9. PubMed ID: 5081450
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of spasmolytic agents in asthma in children].
    Chmielewska D, Przybylska H.
    Pediatr Pol; 1972 Oct 14; 47(6):711-7. PubMed ID: 5038552
    [No Abstract] [Full Text] [Related]

  • 11. [Spirographic results in clinical administration of hexoprenalin].
    Pall H, Schlick W.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):117-21. PubMed ID: 5547428
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 14. A multi-clinic double-blind trial of salbutamol in bronchial asthma.
    Kawakami Y.
    Postgrad Med J; 1971 Mar 16; 47():Suppl:71-4. PubMed ID: 4929397
    [No Abstract] [Full Text] [Related]

  • 15. [News in asthma therapy. Special consideration of the modern selective 2 -stimulators].
    Scherrer M, Bachofen H.
    Schweiz Med Wochenschr; 1972 Jul 29; 102(30):1054-60. PubMed ID: 4633464
    [No Abstract] [Full Text] [Related]

  • 16. [The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
    Cardaci G, Vittore F, Bussa B.
    Clin Ter; 1968 Jun 30; 44(6):533-41. PubMed ID: 5736873
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of a new selective beta-adrenergic receptor stimulant.
    Chervinsky P.
    Ann Allergy; 1971 Dec 30; 29(12):627-30. PubMed ID: 4942442
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q.
    Wien Med Wochenschr; 1971 May 29; 121(22):455-7. PubMed ID: 5092121
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
    Nachtigall C.
    Med Monatsschr; 1968 Dec 29; 22(12):555-7. PubMed ID: 5709425
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.